Hosseinion Warren
SEC Form 4 insider trading activity
Hosseinion Warren has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VRXA, NUTX, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 29, 2026.
On the most recent filing, Hosseinion Warren is listed as Director at Veraxa Biotech AG. Inside the rolling window, Hosseinion Warren reported 2 open-market purchases totaling $34K in VRXA and NUTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 252 NUTX shares on Mar 19, 2026, worth $24K.
Companies traded
Other insiders at VRXA
Insider Buying
$34K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hosseinion Warren made?
Hosseinion Warren has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including VRXA, NUTX since 2026.
Which companies does Hosseinion Warren trade?
Hosseinion Warren has filed SEC Form 4 disclosures for 2 companies, including VRXA, NUTX.
When was Hosseinion Warren's most recent SEC Form 4 filing?
Hosseinion Warren's most recent SEC Form 4 filing on Tracefour is dated Sep 29, 2026.
What is Hosseinion Warren's total buy and sell value in the current window?
Inside the rolling retention window, Hosseinion Warren bought $34K and sold $0 based on SEC Form 4 filings.
What was Hosseinion Warren's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 252 NUTX shares on 2026-03-19, worth $24K, per SEC Form 4 filings.